We found downregulation of the NF-κB1, NF-κB2, and Rel genes in T-cell LGLL cases at 4.557-fold, 3.771-fold, and 2.632-fold, respectively. This evidence concerns the gene NFKB1 and T-cell large granular lymphocyte leukemia.